Pfizer Stock Market Sentiment

PFE -  USA Stock  

USD 51.59  1.50  2.99%

Pfizer investor sentiment overview provides quick insight into current market opportunities from investing in Pfizer Inc. The current market sentiment together Pfizer's historical and current headlines can help investors to time the market. Many technical investors use Pfizer Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Pfizer Hype Analysis, Pfizer Correlation and Pfizer Performance.
  
Refresh
Pfizer stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pfizer daily returns and investor perception about the current pice of Pfizer Inc as well as its diversification or hedging effects on your existing portfolios.

Pfizer Latest Sentiment Indicators

200 Day MA
50.22
Short Percent
0.0138
Short Ratio
2.78
Shares Short Prior Month
68 M
50 Day MA
50.62
52 Week Low
37.54
Shares Short
77.2 M

Pfizer Inc Current Investor Sentiment

Investor biases related to Pfizer's public news can be used to forecast risks associated with investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Pfizer.

Pfizer Maximum Pain Price across 2022-06-24 Option Contracts

Pfizer's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Pfizer close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Pfizer's options.
over three months ago at www.msn.com         
Johnson Johnson stock rises Wednesday, still underperforms market - msnNOW
news
over three months ago at www.macroaxis.com         
Exercise or conversion by Mcdermott Michael of 12340 shares of Pfizer subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Payment of 1795 shares by William Carapezzi of Pfizer subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Exercise or conversion by Sally Susman of 63580 shares of Pfizer subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Albert Bourla of 362427 shares of Pfizer subject to Rule 16b-3
Macroaxis News
over three months ago at www.marketwatch.com         
Acquisition by Frank DAmelio of 111516 shares of Pfizer subject to Rule 16b-3
marketwatch News
over three months ago at www.macroaxis.com         
Exercise or conversion by Sally Susman of 76895 shares of Pfizer subject to Rule 16b-3
Macroaxis News
over three months ago at www.marketwatch.com         
Catalyst Pharmaceuticals Inc. stock falls Tuesday, underperforms market - MarketWatch
marketwatch News
over three months ago at www.macroaxis.com         
Acquisition by Jennifer Damico of 1592 shares of Pfizer subject to Rule 16b-3
Macroaxis News
over three months ago at www.nasdaq.com         
Should Value Investors Pick Pfizer Stock For Now - Nasdaq
nasdaq News
over three months ago at www.benzinga.com         
Why Pfizer Shares Are Trading Lower Today - Benzinga
benzinga news
over three months ago at pulse2.com         
Pfizer Stock Why The Price Fell Today - Pulse 2.0
news
over three months ago at www.nasdaq.com         
Even with 40b in Projected Earnings, it is Likely that Pfizer Inc. Stock Has Already Peaked, and Her...
nasdaq News
over three months ago at www.fool.com         
This 1 Number Could Supercharge Pfizer Stock by 40 percent or More - The Motley Fool
fool News
over three months ago at finance.yahoo.com         
Pfizers COVID product sales to top 50 billion this year, investors want more - Yahoo Finance
Yahoo News
There is far too much social signal, news, headlines, and media speculation about Pfizer that is available to investors today. That information is available publicly through Pfizer media outlets and privately through word of mouth or via Pfizer internal channels. However, regardless of the origin, that massive amount of Pfizer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pfizer news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pfizer relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pfizer's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pfizer alpha.

Pfizer Performance against DOW

 Price Growth (%)  
      Timeline 
1
EPS Estimate03/31/2022
2
Acquisition by Joseph Echevarria of 836 shares of Pfizer sub...04/04/2022
3
Acquisition by Jennifer Damico of tradable shares of Pfizer ...04/12/2022
4
Acquisition by Jennifer Damico of 260 shares of Pfizer subje...04/14/2022
5
Acquisition by Dan Littman of 4059 shares of Pfizer subject ...04/29/2022
6
EPS Reported05/03/2022
7
Amgen Inc. stock rises Wednesday, still underperforms market...05/04/2022
8
Mid-Day Market Update U.S. Stocks Turn Lower Biohaven Pharma...05/10/2022
9
Discretionary transaction by Mikael Dolsten of 15167 shares ...05/12/2022
10
Pfizer exotic insider transaction detected05/13/2022
11
Pfizer exotic insider transaction detected05/16/2022
12
Acquisition by Jennifer Damico of tradable shares of Pfizer ...05/17/2022
13
Acquisition by Jennifer Damico of tradable shares of Pfizer ...05/19/2022
14
Better Dividend Stock Pfizer or Merck - The Motley Fool05/26/2022
15
Acquisition by Albert Bourla of tradable shares of Pfizer su...05/31/2022
16
Pfizer Up 5.5 percent Since Last Earnings Report Can It Cont...06/02/2022
17
Sale by Jennifer Damico of 4218 shares of Pfizer06/08/2022
18
Pfizer Stock The Pain Might Not Be Over - Seeking Alpha06/14/2022
19
Acquisition by Jennifer Damico of tradable shares of Pfizer ...06/16/2022
20
EPS Estimate06/21/2022
21
Incyte Corp. stock outperforms market on strong trading day ...06/24/2022
Please check Pfizer Hype Analysis, Pfizer Correlation and Pfizer Performance. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.59
Market Capitalization
281 B
Quarterly Revenue Growth YOY
0.77
Return On Assets
0.12
Return On Equity
0.34
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.